Pacific Biosciences Of California (PACB) Capital Expenditures (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.43% |
| Dec 31, 2025 | 1,101.16% |
| Sep 30, 2025 | -115.64% |
| Jun 30, 2025 | -60.40% |
| Mar 31, 2025 | -14.10% |
| Dec 31, 2024 | 305.46% |
| Sep 30, 2024 | -153.21% |
| Jun 30, 2024 | -61.87% |
| Mar 31, 2024 | 91.65% |
| Dec 31, 2023 | 143.86% |
| Sep 30, 2023 | -63.40% |
| Jun 30, 2023 | -39.05% |
| Mar 31, 2023 | -24.12% |
| Dec 31, 2022 | 17.07% |
| Sep 30, 2022 | 4.23% |
| Jun 30, 2022 | 10.47% |
| Mar 31, 2022 | 28.01% |
| Jun 30, 2021 | 291.27% |
| Mar 31, 2021 | 498.51% |
| Dec 31, 2020 | -87.50% |
| Sep 30, 2020 | 68.03% |
| Jun 30, 2020 | 172.65% |
| Mar 31, 2020 | -17.02% |
| Dec 31, 2019 | -82.99% |
| Sep 30, 2019 | 35.24% |
| Jun 30, 2019 | -51.08% |
| Mar 31, 2019 | 2,060.34% |
| Dec 31, 2018 | -39.58% |
| Sep 30, 2018 | -92.92% |
| Jun 30, 2018 | 294.19% |
| Mar 31, 2018 | -67.55% |
| Dec 31, 2017 | -67.45% |
| Sep 30, 2017 | -5.54% |
| Jun 30, 2017 | 29.24% |
| Mar 31, 2017 | 0.64% |
| Dec 31, 2016 | 15.21% |
| Sep 30, 2016 | -17.76% |
| Jun 30, 2016 | 512.25% |
| Mar 31, 2016 | -47.95% |
| Dec 31, 2015 | 91.29% |
| Sep 30, 2015 | -51.94% |
| Jun 30, 2015 | 33.19% |
| Mar 31, 2015 | 50.31% |
| Dec 31, 2014 | 151.05% |
| Sep 30, 2014 | -59.14% |
| Jun 30, 2014 | -2.52% |
| Mar 31, 2014 | 367.65% |
| Dec 31, 2013 | -55.65% |
| Sep 30, 2013 | -17.86% |
| Jun 30, 2013 | -5.72% |
| Mar 31, 2013 | -32.50% |
| Dec 31, 2012 | -8.71% |
| Sep 30, 2012 | -4.93% |
| Jun 30, 2012 | 85.04% |
| Mar 31, 2012 | -80.95% |
| Dec 31, 2011 | -36.32% |
| Sep 30, 2011 | -44.82% |
| Jun 30, 2011 | 173.53% |
| Mar 31, 2011 | 21.72% |
| Dec 31, 2010 | 18.40% |